With a team of 100 highly-skilled engineers and designers at the company’s headquarters in Cambridge, CMR has more than doubled in size in the past ten months.
The company behind the Versius surgical robotic system aims to make minimal access surgery available to all those who need it by breaking down the barriers that exist within the surgical robot market.
Versius was inspired by the human arm, with its remarkable dexterity, flexibility and reach. Enabled by a unique robotic wrist, the CMR robot system combines the ability and dexterity of a surgeon with the benefits of robotics. CMR has filled more than 150 patents, a number which increases on a weekly basis.
In July 2016, the company announced the completion of its Series A financing, which raised more than $20m.
The company prides itself on its strong team-based culture. On announcing its 100th employee, CMR gave each employee a £100 John Lewis voucher as recognition of their hard work and dedication.
“We’re growing at a rate that’s faster that we could ever have imagined. CMR has an ambitious task ahead, bringing the world’s smallest and most affordable surgical robot to the international market. Around six million people undergo open surgery unnecessarily globally each year because laparoscopic, or key hole, surgery is unavailable to them. Versius will ensure that patients receive the best surgical procedures possible and that surgeons are given the best tools for the job. We want to thank each and every member of our team helping us realise our vision to revolutionise surgery worldwide,” commented Martin Frost, Chief Executive Officer, CMR.
Notes to Editors:
About CMR Surgical
CMR Surgical is a private company developing the next-generation universal robotic system for minimal access (or “keyhole”) surgery.
The vision behind CMR is to make minimal access surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically. This will transform the existing market for surgical robotics.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.
CMR Surgical was formed in 2014 and has its headquarters in Cambridge, United Kingdom. The company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.
Investors in CMR Surgical include ABB Technology Ventures, LGT Global, Cambridge Innovation Capital and Escala Capital.
For further information, please visit: www.cmrsurgical.com